FdaApplication
ANDA 204513
Identifiers
- fda_app_no: ANDA204513
Properties
| Property | Value |
|---|---|
| applicant_name | NCM USA BRONX LLC |
| application_type | ANDA |
| approval_date | 2014-11-28 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SODIUM FLUORIDE F-18 | SODIUM FLUORIDE F-18 | 10-200mCi/ML | INJECTABLE;INTRAVENOUS |
1 product